hydrocortisone acetate has been researched along with Adenocarcinoma of Lung in 1 studies
hydrocortisone acetate: RN given refers to cpd without isomeric designation
Adenocarcinoma of Lung: A carcinoma originating in the lung and the most common lung cancer type in never-smokers. Malignant cells exhibit distinct features such as glandular epithelial, or tubular morphology. Mutations in KRAS, EGFR, BRAF, and ERBB2 genes are associated with this cancer.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pongcharoen, P | 1 |
| Chanprapaph, K | 1 |
| Vachiramon, V | 1 |
1 other study available for hydrocortisone acetate and Adenocarcinoma of Lung
| Article | Year |
|---|---|
Papulopustular eruptions in a 32-year-old woman after lung cancer treatment.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Antineoplastic Agents; Dermatologic Agents; Drug Erup | 2011 |